Blog

When is Eye Surgery a Necessity?

Submitted by Elman Retina Group on February 29, 2016

When dealing with most eye conditions, treatment consists of eye drops, other medication, and sometimes eye exercises. As time goes on, your condition may worsen to the point where medication doesn’t work any more. Once this begins to affect your quality of life, it may be time to speak with our doctors about having eye…Read More→

What is wet AMD (wet macular degeneration)?

Submitted by Elman Retina Group on January 28, 2016

The number one cause of vision loss is a condition known as age-related macular degeneration (AMD). It’s been estimated that as many as 10 million people in the United States are currently dealing with this disease. AMD and the Eye The back of your eye is lined with a delicate tissue called the retina.  The…Read More→

What are the differences between Macular Holes and Macular Degeneration?

Submitted by Elman Retina Group on January 20, 2016

Inside your eyes, there is a thin tissue along the back of the inner surface called the retina, which collects visual images and sends this information up the optic nerves to the brain. The macula is a spot at the center of the retina, and is necessary for performing focusing tasks such as reading fine…Read More→

What is Central Retinal Artery Occlusion?

Submitted by Elman Retina Group on January 18, 2016

First described in 1859, central retinal artery occlusion occurs when the central artery that supplies blood to the retina becomes blocked. (The retina is a thin tissue on the back of the inner eye that gathers visual images). The most common cause of an arterial block is an embolus. Emboli are clots (often formed by…Read More→

Treatment of diabetic patients undergoing monthly treatment with Lucentis

Submitted by Elman Retina Group on December 3, 2015

This was the poster Dr. Elman presented at the annual meeting of the American Academy of Ophthalmology held in Las Vegas two weeks ago. The poster shows that treatment of diabetic patients undergoing monthly treatment with Lucentis for diabetic macular edema unexpectedly benefited from improvement in their severity of diabetic retinopathy. Essentially, Lucentis treatment “turned…Read More→

Lucentis effective for proliferative diabetic retinopathy

Submitted by Elman Retina Group on November 13, 2015

Elman Retina Group key center in NIH-funded clinical trial – marks first major advance in therapy in 40 years A clinical trial funded by the National Institutes of Health has found that the drug ranibizumab (Lucentis) is highly effective in treating proliferative diabetic retinopathy. The trial, conducted by the Diabetic Retinopathy Clinical Research Network (DRCR.net) compared Lucentis with a type of…Read More→

The Benefits of ForeseeHome for Macular Degeneration

Submitted by Elman Retina Group on November 3, 2015

At the Elman Retina Group, we believe that the best patient outcomes happen when best-practice interventions are provided alongside prevention. It’s why we stand behind the ForeseeHome AMD Monitoring Program as an advanced and powerful tool to help maximize patients’ quality of living. What is Age-Related Macular Degeneration (AMD)? At least 10 million people in the United…Read More→

What is Retinal Detachment?

Submitted by Elman Retina Group on October 2, 2015

Here at Elman retina Group, we diagnose and treat retinal detachment in order to help you preserve your vision. Retinal Detachment The retina is located on the inside back of the eye and is connected to the optic nerve. It is responsible for transmitting light or visual images to the brain through the optic nerve…Read More→